Caenorhabditis elegans as a model system for Parkinson's disease

被引:30
|
作者
Schmidt, Enrico
Seifert, Mark
Baumeister, Ralf
机构
[1] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, Ctr Biochem & Mol Cell Res, Fac Med, DE-79104 Freiburg, Germany
[2] Univ Freiburg, Freiburg Ctr Syst Biol, ZBSA, DE-79104 Freiburg, Germany
关键词
Caenorhabditis elegans; dopaminergic system; Parkinson's disease; endoplasmic reticulum stress; oxidative stress;
D O I
10.1159/000101845
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is one of the most common age-related neuroclegenerative diseases that is characterized by selective loss of dopaminergic neurons. Despite recent findings from mammalian model systems, molecular mechanisms of the pathophysiology are poorly understood. Given the high conservation of molecular pathways from invertebrates to mammalians, combined with technical advantages, such as high-throughput approaches, Caenorhabditis elegans represents a powerful system for the identification of factors involved in neurodegeneration. In this review we describe that C elegans can be used to advance our understanding of the genetic mechanisms implicated in these disorders.
引用
收藏
页码:199 / 217
页数:19
相关论文
共 50 条
  • [41] Caenorhabditis elegans: a model system for systems neuroscience
    Sengupta, Piali
    Samuel, Aravinthan D. T.
    CURRENT OPINION IN NEUROBIOLOGY, 2009, 19 (06) : 637 - 643
  • [42] Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond
    Chandler, Rachael J.
    Cogo, Susanna
    Lewis, Patrick A.
    Kevei, Eva
    BIOSCIENCE REPORTS, 2021, 41 (09)
  • [43] Chlorogenic acid delays the progression of Parkinson's disease via autophagy induction in Caenorhabditis elegans
    He, Chang-Long
    Tang, Yong
    Wu, Jian-Ming
    Long, Tao
    Yu, Lu
    Teng, Jin-Feng
    Qiu, Wen-Qiao
    Pan, Rong
    Yu, Chong-Lin
    Qin, Da-Lian
    Wu, An-Guo
    Zhou, Xiao-Gang
    NUTRITIONAL NEUROSCIENCE, 2023, 26 (01) : 11 - 24
  • [44] Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model
    Link, CD
    Taft, A
    Kapulkin, V
    Duke, K
    Kim, S
    Fei, Q
    Wood, DE
    Sahagan, BG
    NEUROBIOLOGY OF AGING, 2003, 24 (03) : 397 - 413
  • [45] C-elegans as a model system to accelerate discovery for Parkinson disease
    Martinez, Bryan A.
    Caldwell, Kim A.
    Caldwell, Guy A.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2017, 44 : 102 - 109
  • [46] The worm in us -: Caenorhabditis elegans as a model of human disease
    Baumeister, R
    Ge, LM
    TRENDS IN BIOTECHNOLOGY, 2002, 20 (04) : 147 - 148
  • [47] Potential Therapeutic Effects of Policosanol from Insect Wax on Caenorhabditis elegans Models of Parkinson's Disease
    Ma, Chenjing
    Feng, Ying
    Li, Xian
    Sun, Long
    He, Zhao
    Gan, Jin
    He, Minjie
    Zhang, Xin
    Chen, Xiaoming
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2023, 18 (1-2) : 127 - 144
  • [48] Development of a dopaminergic neurodegeneration assay using laser cytometry of <it>Caenorhabditis elegans</it> models of Parkinson's disease
    Akano, Emmanuel
    Casazza, Julia
    Dranchak, Patricia
    Moritz, Amy
    Free, R.
    Inglese, James
    Sibley, David
    FASEB JOURNAL, 2020, 34
  • [49] Use of Caenorhabditis elegans to Unravel the Tripartite Interaction of Kynurenine Pathway, UPRmt and Microbiome in Parkinson's Disease
    Viau, Charles
    Nouar, Alyssa
    Xia, Jianguo
    BIOMOLECULES, 2024, 14 (11)
  • [50] Development of a dopaminergic neurodegeneration assay using laser cytometry of Caenorhabditis elegans models of Parkinson's disease
    Akano, Emmanuel
    Casazza, Julia
    Dranchak, Patricia
    Anderson, Emily
    Moritz, Amy
    Free, R.
    Steiner, Joseph
    Inglese, James
    Sibley, David
    FASEB JOURNAL, 2021, 35